Insider · CIK 0001768432

Orlinger Klaus

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001768432

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-04-15	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+367K sh	—	—	367,300
2023-04-14	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+194K sh	—	—	194,200
2022-06-30	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+48.4K sh	—	—	48,350
2022-04-19	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+48.4K sh	—	—	48,350
2022-02-01	HOOKHOOKIPA Pharma Inc.A Award	Chief Scientific Officer	AAward	+9,188 sh	$3.00	+$27.6K	10,404
2022-02-01	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+12.7K sh	$3.00	+$38K	12,654
2021-04-19	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+26.1K sh	—	—	26,050
2020-07-20	HOOKHOOKIPA Pharma Inc.A Award	Chief Scientific Officer	AAward	+1,216 sh	—	—	1,216
2020-04-20	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+30K sh	—	—	0
2020-01-21	HOOKHOOKIPA Pharma Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,789 sh	$0.10	+$678.9	6,789
2020-01-21	HOOKHOOKIPA Pharma Inc.S Sale	Chief Scientific Officer	SSale	−6,789 sh	$12.02	−$81.6K	0
2020-01-21	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,789 sh	—	—	7,741
2020-01-16	HOOKHOOKIPA Pharma Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+1,140 sh	$0.10	+$114	1,140
2020-01-16	HOOKHOOKIPA Pharma Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+571 sh	$0.10	+$57.1	1,711
2020-01-16	HOOKHOOKIPA Pharma Inc.S Sale	Chief Scientific Officer	SSale	−1,711 sh	$11.56	−$19.8K	0
2020-01-16	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−1,140 sh	—	—	0
2020-01-16	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−571 sh	—	—	14,530
2020-01-14	HOOKHOOKIPA Pharma Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,358 sh	$0.10	+$735.8	7,358
2020-01-14	HOOKHOOKIPA Pharma Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+1,142 sh	$0.10	+$114.2	8,500
2020-01-14	HOOKHOOKIPA Pharma Inc.S Sale	Chief Scientific Officer	SSale	−8,500 sh	$11.30	−$96.1K	0
2020-01-14	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,358 sh	—	—	0
2020-01-14	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−1,142 sh	—	—	1,140
2019-04-17	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+42.8K sh	—	—	42,784

Recent filings

Accepted (ET)
Apr 174
Orlinger Klaus0001415889-24-010961
SEC(opens sec.gov)
Apr 184
Orlinger Klaus0001104659-23-046893
SEC(opens sec.gov)
Jul 14
Orlinger Klaus0001104659-22-076833
SEC(opens sec.gov)
Apr 204
Orlinger Klaus0001104659-22-047859
SEC(opens sec.gov)
Feb 14
Orlinger Klaus0001104659-22-010541
SEC(opens sec.gov)
Apr 214
Orlinger Klaus0001104659-21-053196
SEC(opens sec.gov)
Jul 224
Orlinger Klaus0001104659-20-085609
SEC(opens sec.gov)
Apr 244
Orlinger Klaus0001104659-20-050692
SEC(opens sec.gov)
Jan 214
Orlinger Klaus0001104659-20-005577
SEC(opens sec.gov)
Jan 164
Orlinger Klaus0001104659-20-004735
SEC(opens sec.gov)

Companies

HOOKIPA Pharma Inc.Chief Scientific OfficerHOOK

Address

C/O HOOKIPA PHARMA INC. 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240

NEW YORK, NY, 10118